Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inflexal V Immunogenicity and Cross-Protection in Elderly
NCT01457027Phase 4Completed
- Sponsor
- Crucell
- Start
- Oct 2011
- Primary completion
- Aug 2012
- Modality
- Nanoparticles, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Inflexal V in influenza, sponsored by Crucell. Started Oct 2011; status: completed.
02
Drugs
Inflexal V
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01457027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01457027.